In February 2023, capiton a German private equity firm, initiated a €248 million GP-led continuation fund transaction, which involved the sale of two leading German high-tech companies Raith and AEMtec from capiton Fund V to a newly established continuation fund “capiton Quantum”. capiton attracted a high-profile group of secondary investors led by Eurazeo and Unigestion alongside existing and new capiton LPs.
Our Opinions Practice served as financial advisor to capiton Fund V and provided a fairness opinion in connection with the transaction. Kroll has previously advised capiton Fund IV and provided a fairness opinion in connection with the single-asset secondary transaction of KD Pharma Group in 2019.
About capiton
Founded in 1999, capiton is a leading private equity firm focused on middle-market investments in the pharma, medtech, industrial technology and responsible consumption sectors across Germany, Austria and Switzerland, currently managing a total fund volume of €1.6 billion.
About Raith and AEMtec
Raith is a global market and technology leader for nanofabrication and engineering equipment and develops, supplies and supports the highest precision systems for the printing and scanning of nanostructures.
AEMtec is a leading full-service provider of customized advanced packaging for cutting-edge micro and optoelectronic systems.
